Eating Disorder: Clinical Trials

2 trials for Eating Disorder, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 enrolling by invitation. 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 22Completed 1, Enrolling by invitation 1

Follow Eating Disorder: new trials by email Literature Review of Eating Disorder trials Research Report on Eating Disorder

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Hormonal Factors in the Treatment of Anorexia Nervosa
Testosterone, Placebo - Anorexia Nervosa, Eating Disorder
Phase 2CompletedMassachusetts General Hospital902010-04-012020-09-02
Co-Feedback Action of Growth Hormone, PP and PYY on Ghrelin in Bulimia
Acipimox, Placebo - Eating Disorder, Bulimia Nervosa
Phase 2Enrolling by invitationCharles University, Czech Republic242003-05-062025-02-19

Narrower conditions

Feeding and Eating Disorders (2)  ·  Anorexia Nervosa (1)  ·  Anxiety Disorders (1)  ·  Bulimia Nervosa (1)  ·  Depression (1)  ·  Psychological Well-Being (1)

Broader conditions

Mental Disorders (2)  ·  Pathological Conditions, Signs and Symptoms (2)  ·  Signs and Symptoms (2)  ·  Signs and Symptoms, Digestive (2)  ·  Behavior (1)  ·  Behavioral Symptoms (1)  ·  Personal Satisfaction (1)

Interventions

Testosterone (1)  ·  acipimox (1)

Sponsors

Charles University, Czech Republic (1)  ·  Massachusetts General Hospital (1)

Countries

United States (1)

Top investigators

Anne Klibanski, MD (1)  ·  Erinne Meenaghan, NP (1)  ·  Karen K Miller, MD (1)  ·  Kvido Smitka, M.D., Ph.D. (1)

Results publications

PMID 31219558, PMID 36798485

NIH funding

R01MH083657 (1)